Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:SESN

Sesen Bio (SESN) Stock Price, News & Analysis

Sesen Bio logo

About Sesen Bio Stock (NASDAQ:SESN)

Key Stats

Today's Range
N/A
50-Day Range
$0.63
$12.99
52-Week Range
N/A
Volume
93,330 shs
Average Volume
1.07 million shs
Market Capitalization
$2.56 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sesen Bio, Inc. engages in designing, engineering, and developing targeted protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.

Receive SESN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sesen Bio and its competitors with MarketBeat's FREE daily newsletter.

SESN Stock News Headlines

Trey Mewes
Sesen Bio (NASDAQ: SESN)
Buffett Dumps $982 Million in BofA Stock—What Does He Know?
Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.
See More Headlines

SESN Stock Analysis - Frequently Asked Questions

Sesen Bio, Inc. (NASDAQ:SESN) released its earnings results on Sunday, November, 7th. The company reported $7.20 EPS for the quarter, beating the consensus estimate of ($1.40) by $8.60.

Sesen Bio's stock reverse split on Wednesday, March 8th 2023. The 1-20 reverse split was announced on Wednesday, March 8th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, March 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sesen Bio investors own include Predictive Oncology (POAI), Ford Motor (F), Zomedica (ZOM), NIO (NIO), Bank of America (BAC), Wells Fargo & Company (WFC) and OPKO Health (OPK).

Company Calendar

Last Earnings
11/07/2021
Today
11/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SESN
Employees
35
Year Founded
N/A

Profitability

Net Income
$-19,880,000.00
Pretax Margin
-59.40%

Debt

Sales & Book Value

Annual Sales
$40 million
Book Value
$0.78 per share

Miscellaneous

Free Float
196,980,000
Market Cap
$2.56 billion
Optionable
Optionable
Beta
0.83
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:SESN) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners